FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hakan Camlica

Research Profile

Chemicals & Drugs

Procedures

Concepts & Ideas

Disorders

Geographic Areas

Turkey

Co-author Network

Publications

TOP 3
S Tuna; Faruk N Aykan; Hakan Camlica; M Dalkilic Calis; Burak Sakar; Erkan Topuz
Prognostic significance of the metastatic lymph node ratio for survival in colon cancer.
R Saip; F Sen; E Ugurel; Zeki Ustuner; Burcak Vural; Hakan Camlica; A Demirkan; Duygu Derin; Yesim Eralp; Ugur Ozbek
Glutathione S-transferase P1 polymorphisms are associated with time to tumor progression in small cell lung cancer patients.
Hilal Oguz Soydinc; Hakan Camlica; Derya Duranyildiz; Ethem Nezih Oral; Vildan Yasasever
Lack of diagnostic potential of Dickkopf-1 in colon and rectum cancers.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hakan Camlica (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: S Tuna; Faruk N Aykan; Hakan Camlica; M Dalkilic Calis; Burak Sakar; Erkan Topuz
Prognostic significance of the metastatic lymph node ratio for survival in colon cancer.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2011;16(3):478-85.
2011: R Saip; F Sen; E Ugurel; Zeki Ustuner; Burcak Vural; Hakan Camlica; A Demirkan; Duygu Derin; Yesim Eralp; Ugur Ozbek
Glutathione S-transferase P1 polymorphisms are associated with time to tumor progression in small cell lung cancer patients.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2011;16(2):241-6.
2011: Hilal Oguz Soydinc; Hakan Camlica; Derya Duranyildiz; Ethem Nezih Oral; Vildan Yasasever
Lack of diagnostic potential of Dickkopf-1 in colon and rectum cancers.
Asian Pacific journal of cancer prevention : APJCP 2011;12(12):3187-9.
2010: Pinar Atukeren; Berna Yavuz; Hilal Oguz Soydinc; Sevim Purisa; Hakan Camlica; M Koray Gumustas; Ibrahim Balcioglu
Variations in systemic biomarkers of oxidative/nitrosative stress and DNA damage before and during the consequent two cycles of chemotherapy in breast cancer patients.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2010;48(10):1487-95.
2010: Zelal Erkisi; Ilhan Yaylim-Eraltan; Akif Turna; Uzay Görmüs; Hakan Camlica; Turgay Isbir
Polymorphisms in the microsomal epoxide hydrolase gene: role in lung cancer susceptibility and prognosis.
Tumori 2010;96(5):756-63.
2009: Nese Guney; Hilal Oguz Soydinc; Mert Basaran; Sevil Bavbek; Duygu Derin; Hakan Camlica; Vildan Yasasever; Erkan Topuz
Serum levels of interleukin-6 and interleukin-10 in Turkish patients with aggressive non-Hodgkin's lymphoma.
Asian Pacific journal of cancer prevention : APJCP 2009;10(4):669-74.
2009: Hasan KARANLIK; Remzi Akturk; Hakan Camlica; Oktar Asoglu
The effect of glyceryl trinitrate ointment on posthemorrhoidectomy pain and wound healing: results of a randomized, double-blind, placebo-controlled study.
Diseases of the colon and rectum 2009;52(2):280-5.
2009: Derya Duranyildiz; Hakan Camlica; Hilal Oguz Soydinc; Duygu Derin; Vildan Yasasever
Serum levels of angiogenic factors in early breast cancer remain close to normal.
Breast (Edinburgh, Scotland) 2009;18(1):26-9.
2008: Hakan Camlica; Derya Duranyildiz; Faruk Tas; Vildan Yasasever
Statistical interpretation of CA125 and Bcl-2 in serum of patients with late stage ovarian cancer.
American journal of clinical oncology 2008;31(6):585-8.
2008: Faruk Tas; Nese Guney; Duygu Derin; Hakan Camlica; Adnan Aydiner; Erkan Topuz
Biweekly administration of gemcitabine and cisplatin chemotherapy in patients with anthracycline and taxane-pretreated metastatic breast cancer.
Investigational new drugs 2008;26(4):363-8.
2008: Faruk Tas; Hakan Camlica; Erkan Topuz
Temozolomide in combination with fotemustine in patients with metastatic melanoma.
Cancer chemotherapy and pharmacology 2008;62(2):293-8.
2008: I Yaylim-Eraltan; Nilüfer Bozkurt; A Ergen; Umit Zeybek; O Ozturk; Soykan Arikan; Yesim Erbil; Ilhami Uslu; Hakan Camlica; TURGAY ISBIR
L-myc gene polymorphism and risk of thyroid cancer.
Experimental oncology 2008;30(2):117-20.
2008: Hakan Camlica; Derya Duranyildiz; Hilal Oguz Soydinc; Ethem Nezih Oral; Vildan Yasasever
The diagnostic value of macrophage migration inhibitory factor (MIF) in gastric cancer.
Pathology oncology research : POR 2008;14(1):79-83.
2008: Duygu Derin; Hilal Oguz Soydinç; Nese Guney; Faruk Tas; Hakan Camlica; Derya Duranyildiz; Vildan Yasasever; Erkan Topuz
Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2008;59(2):240-5.
2008: Faruk Tas; Derya Duranyildiz; Hilal Oguz Soydinc; Hakan Camlica; Vildan Yasasever; Erkan Topuz
Circulating levels of vascular endothelial growth factor (VEGF), matrix metalloproteinase-3 (MMP-3), and BCL-2 in malignant melanoma.
Medical oncology (Northwood, London, England) 2008;25(4):431-6.
2008: Faruk Tas; Derya Duranyildiz; Hilal Oguz Soydinc; Hakan Camlica; Vildan Yasasever; Erkan Topuz
Effect of zoledronic acid on serum angiogenic factors in patients with bone metastases.
Medical oncology (Northwood, London, England) 2008;25(3):346-9.
2008: Nese Guney; Hilal Oguz Soydinc; Duygu Derin; Faruk Tas; Hakan Camlica; Derya Duranyildiz; Vildan Yasasever; Erkan Topuz
Serum levels of intercellular adhesion molecule ICAM-1 and E-selectin in advanced stage non-small cell lung cancer.
Medical oncology (Northwood, London, England) 2008;25(2):194-200.
2007: Vildan Yasasever; Hakan Camlica; Derya Duranyildiz; Hilal Oguz Soydinc; Faruk Tas; Nejat Dalay
Macrophage migration inhibitory factor in cancer.
Cancer investigation 2007;25(8):715-9.
2007: Faruk Tas; Duygu Derin; Nese Guney; Hakan Camlica; Adnan Aydiner; Erkan Topuz
Addition of topotecan to standard cisplatin/etoposide combination in patients with extended stage small cell lung carcinoma.
Lung cancer (Amsterdam, Netherlands) 2007;57(1):79-83.
2007: A Yazar; Z Ustüner; Burak Sakar; E Kaytan Sağlam; Hakan Camlica; Faruk N Aykan
Adjuvant chemoradiation for patients with adenocarcinoma of the pancreas: an expirence of single institute.
Medical oncology (Northwood, London, England) 2007;24(4):384-7.
2007: Duygu Derin; Hilal Oguz Soydinc; Nese Guney; Faruk Tas; Hakan Camlica; Derya Duranyildiz; Vildan Yasasever; Erkan Topuz
Serum IL-8 and IL-12 levels in breast cancer.
Medical oncology (Northwood, London, England) 2007;24(2):163-8.
2006: Faruk Tas; Sidika Kurul; Hakan Camlica; Erkan Topuz
Malignant melanoma in Turkey: a single institution's experience on 475 cases.
Japanese journal of clinical oncology 2006;36(12):794-9.
2006: Faruk Tas; Derya Duranyildiz; Hilal Oguz Soydinc; Hakan Camlica; Vildan Yasasever; Erkan Topuz
Circulating serum levels of angiogenic factors and vascular endothelial growth factor receptors 1 and 2 in melanoma patients.
Melanoma research 2006;16(5):405-11.
2006: Faruk Tas; Derya Duranyildiz; Hilal Oguz Soydinc; Hakan Camlica; Vildan Yasasever; Erkan Topuz
Serum vascular endothelial growth factor (VEGF) and bcl-2 levels in advanced stage non-small cell lung cancer.
Cancer investigation 2006;24(6):576-80.
2006: Faruk Tas; Derya Duranyildiz; Hilal Oguz Soydinc; Hakan Camlica; Vildan Yasasever; Erkan Topuz
Serum vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8) levels in small cell lung cancer.
Cancer investigation 2006;24(5):492-6.
2006: Faruk Tas; Sidika Kurul; Hakan Camlica; Erkan Topuz
Intermediate dose interferon alpha in adjuvant treatment for high-risk melanoma: a single institution's experience.
Medical oncology (Northwood, London, England) 2006;23(4):471-7.
2006: Nese Guney; Hilal Oguz Soydine; Duygu Derin; Faruk Tas; Hakan Camlica; Derya Duranyildiz; Vildan Yasasever; Erkan Topuz
Serum and urine survivin levels in breast cancer.
Medical oncology (Northwood, London, England) 2006;23(3):335-9.
2006: Faruk Tas; Derya Duranyildiz; Hilal Oguz Soydinc; Hakan Camlica; Vildan Yasasever; Erkan Topuz
The value of serum bcl-2 levels in advanced epithelial ovarian cancer.
Medical oncology (Northwood, London, England) 2006;23(2):213-7.
2005: Faruk Tas; Andac Argon; Hakan Camlica; Erkan Topuz
Temozolomide in combination with cisplatin in patients with metastatic melanoma: a phase II trial.
Melanoma research 2005;15(6):543-8.
2005: Sidika Kurul; Faruk Taş; Nesimi Büyükbabani; Ayse Mudun; Can Baykal; Hakan Camlica
Different manifestations of malignant melanoma in the breast: a report of 12 cases and a review of the literature.
Japanese journal of clinical oncology 2005;35(4):202-6.
2005: Faruk Tas; Derya Duranyildiz; Andac Argon; Hilal Oğuz; Hakan Camlica; Vildan Yasasever; Erkan Topuz
Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer.
Medical oncology (Northwood, London, England) 2005;22(4):353-8.
2005: Faruk Tas; Hilal Oguz Soydinc; Andac Argon; Derya Duranyildiz; Hakan Camlica; Vildan Yasasever; Erkan Topuz
The value of serum levels of IL-6, TNF-alpha, and erythropoietin in metastatic malignant melanoma: serum IL-6 level is a valuable prognostic factor at least as serum LDH in advanced melanoma.
Medical oncology (Northwood, London, England) 2005;22(3):241-6.
2005: Faruk Tas; Derya Duranyildiz; Andac Argon; Hilal Oguz Soydinc; Hakan Camlica; Vildan Yasasever; Erkan Topuz
Apoptosis of lymphocytes in peripheral blood of patients with melanoma.
Medical oncology (Northwood, London, England) 2005;22(2):177-81.
2005: Faruk Tas; Derya Duranyildiz; Hilal Oguz Soydinc; Hakan Camlica; Ethem Nezih Oral; Vildan Yasasever; Erkan Topuz
The value of serum Bcl-2 levels in advanced lung cancer patients.
Medical oncology (Northwood, London, England) 2005;22(2):139-43.
2005: Faruk Tas; Zeki Ustuner; Gulbeyaz Can; Yesim Eralp; Hakan Camlica; Mert Basaran; Hakan Karagol; Burak Sakar; Rian Disci; Erkan Topuz
The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients.
Acta oncologica (Stockholm, Sweden) 2005;44(2):161-7.
2005: Faruk Tas; Hasan Hansel; Ahmet Belce; Sennur Ilvan; Andac Argon; Hakan Camlica; Erkan Topuz
Oxidative stress in breast cancer.
Medical oncology (Northwood, London, England) 2005;22(1):11-5.
2004: Faruk Tas; Derya Duranyildiz; Andac Argon; Hilal Oguz Soydinc; Hakan Camlica; Vildan Yasasever; Erkan Topuz
Serum bcl-2 and survivin levels in melanoma.
Melanoma research 2004;14(6):543-6.
2004: N Süleyman Ozyalçin; Gül Köknel Talu; Hakan Camlica; Serap Erdine
Efficacy of coeliac plexus and splanchnic nerve blockades in body and tail located pancreatic cancer pain.
European journal of pain (London, England) 2004;8(6):539-45.
2004: Andac Argon; Mert Basaran; Fulya Yaman; Yavuz Dizdar; Burak Sakar; Hakan Camlica; Sevil Bavbek; Harzem Ozger; Emin Darendeliler; Haluk Onat
Ewing's sarcoma of the axial system in patients older than 15 years: dismal prognosis despite intensive multiagent chemotherapy and aggressive local treatment.
Japanese journal of clinical oncology 2004;34(11):667-72.
2004: Burak Sakar; Zeki Ustuner; Hakan Karagol; Gorkem Aksu; Hakan Camlica; N Faruk Aykan
Prognostic features and survival of inoperable hepatocellular carcinoma in Turkish patients with cirrhosis.
American journal of clinical oncology 2004;27(5):489-93.
2004: N S Ozyalcin; A Yucel; Hakan Camlica; N Dereli; O K Andersen; L Arendt-Nielsen
Effect of pre-emptive ketamine on sensory changes and postoperative pain after thoracotomy: comparison of epidural and intramuscular routes.
British journal of anaesthesia 2004;93(3):356-61.
2004: H Arzu Ergen; Hüsrev Hatemi; Bedia Agachan; Hakan Camlica; TURGAY ISBIR
Angiotensin-I converting enzyme gene polymorphism in Turkish type 2 diabetic patients.
Experimental & molecular medicine 2004;36(4):345-50.
2004: Ayhan Bilir; Vahit Ozmen; Mustafa Kecer; Yesim Eralp; Neslihan Cabioglu; Bulent Ahishali; Bulent Agizhali; Hakan Camlica; Adnan Aydiner
Thymidine labeling index: prognostic role in breast cancer.
American journal of clinical oncology 2004;27(4):400-6.
2004: Cetin Karaca; Nilay Güler; Aziz Yazar; Hakan Camlica; Kadir Demir; Gonca Yildirim
Is lower socio-economic status a risk factor for Helicobacter pylori infection in pregnant women with hyperemesis gravidarum?
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 2004;15(2):86-9.
2004: Bulent Bayraktar; ilker Yucesir; Adnan Ozturk; Aysegül Cakmak; Nurcan Taskara; Aysin Cetiner Kale; Deniz Demiryurek; Alp Bayramoglu; Hakan Camlica
Change of quadriceps angle values with age and activity.
Saudi medical journal 2004;25(6):756-60.
2004: Faruk Tas; Vildan Yasasever; Derya Duranyildiz; Hakan Camlica; Zeki Ustuner; Adnan Aydiner; Erkan Topuz
Clinical value of protein S100 and melanoma-inhibitory activity (MIA) in malignant melanoma.
American journal of clinical oncology 2004;27(3):225-8.
2004: Faruk Tas; Cumhur Demir; Hakan Camlica; Zeki Ustuner; Erkan Topuz
Second-Line docetaxel and gemcitabine combination chemotherapy in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: a phase II trial.
Medical oncology (Northwood, London, England) 2004;21(3):233-40.
2003: Faruk Tas; Hakan Camlica; Sidika Kurul; Adnan Aydiner; Erkan Topuz
Combination chemotherapy with docetaxel and irinotecan in metastatic malignant melanoma.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2003;15(3):132-5.
2003: Ozlem Bitisik; Hakan Camlica; Derya Duranyildiz; Faruk Tas; Sidika Kurul; Nejat Dalay
Detection of circulating melanoma cells by a two-marker polymerase chain reaction assay in relation to therapy.
Journal of biochemistry and molecular biology 2003;36(2):173-8.
2002: Basak Yücel; Süleyman Ozyalcin; H Ozlem Sertel; Hakan Camlica; Aysegül Ketenci; Gül Köknel Talu
Childhood traumatic events and dissociative experiences in patients with chronic headache and low back pain.
The Clinical journal of pain 2002;18(6):394-401.
2002: Faruk Tas; Yesim Eralp; Mert Basaran; Burak Sakar; Süleyman Alici; Andac Argon; Gulistan Bulutlar; Hakan Camlica; Adnan Aydiner; Erkan Topuz
Anemia in oncology practice: relation to diseases and their therapies.
American journal of clinical oncology 2002;25(4):371-9.
2002: Ilhan Yaylim; TURGAY ISBIR; Oguz Oztürk; Akif Turna; Turgut Işitmangil; Ferzat Zonüzi; Hakan Camlica
Is there any correlation between restriction fragment length polymorphism of the L-MYC gene and metastasis of human nonsmall cell lung cancer?
Cancer genetics and cytogenetics 2002;134(2):118-22.
2002: TURGAY ISBIR; Ilhan Yaylim; Soykan Arikan; Esra Kaytan; Tamer Karşidağ; Savas Bayrak; Hakan Camlica
Close correlation between restriction fragment length polymorphism of L-myc gene and susceptibility to gastric cancer.
Cancer detection and prevention 2002;26(6):454-7.
2001: Mert Basaran; E S Bavbek; Burak Sakar; Yesim Eralp; Süleyman Alici; Faruk Tas; Fulya Yaman; O Dogan O; Hakan Camlica; Haluk Onat
Treatment of aggressive non-Hodgkin's lymphoma with dose-intensified epirubicin in combination of cyclophosphamide, vincristine, and prednisone (CEOP-100): a phase II study.
American journal of clinical oncology 2001;24(6):570-5.
2001: Rasim Meral; Derya Duranyildiz; Faruk Tas; Hakan Camlica; Vildan Yasasever; Sidika Kurul; Nejat Dalay
Prognostic significance of melanoma inhibiting activity levels in malignant melanoma.
Melanoma research 2001;11(6):627-32.
2000: Vildan Yasasever; Maktav Dincer; Hakan Camlica; Derya Duranyildiz; Nejat Dalay
Serum c-erb B2 oncoprotein levels are elevated in recurrent and metastatic breast cancer.
Clinical biochemistry 2000;33(4):315-7.
2000: Faruk Tas; N Faruk Aykan; Adnan Aydiner; Kazim Uygun; Mert Basaran; Hakan Camlica; Erkan Topuz
The roles of chemotherapy and surgery in gastric carcinoma and the influence of prognostic factors on survival.
American journal of clinical oncology 2000;23(1):53-7.
2000: Vildan Yasasever; Faruk Tas; Derya Duranyildiz; Hakan Camlica; Sidika Kurul; Nejat Dalay
Serum levels of the soluble adhesion molecules in patients with malignant melanoma.
Pathology oncology research : POR 2000;6(1):42-5.
1999: Faruk Tas; Adnan Aydiner; Erkan Topuz; Hakan Camlica; Pinar Saip; Yesim Eralp
Factors influencing the distribution of metastases and survival in extensive disease small cell lung cancer.
Acta oncologica (Stockholm, Sweden) 1999;38(8):1011-5.
1998: G Tokuç; O Doğan; Irfan Ayan; Rejin Kebudi; S Doğan; Misten Demiryont; Hakan Camlica
Prognostic value of proliferating cell nuclear antigen immunostaining in pediatric rhabdomyosarcomas.
Acta paediatrica Japonica; Overseas edition 1998;40(6):573-9.
1997: Vildan Yasasever; M Dinçer; Hakan Camlica; D Karaloğlu; Nejat Dalay
Utility of CA 15-3 and CEA in monitoring breast cancer patients with bone metastases: special emphasis on "spiking" phenomena.
Clinical biochemistry 1997;30(1):53-6.
1997: Vildan Yasasever; M Dinçer; Hakan Camlica; Derya Duranyildiz; Nejat Dalay
Evaluation of phosphohexose isomerase as a metastasis marker in breast cancer patients.
European journal of gynaecological oncology 1997;18(5):397-9.